Linda Henneman
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Engineering of induced pluripotent stem cells for the efficient development of non-alloreactive, hypoimmunogenic CD8αβ CAR-T cells.
Journal: Frontiers in immunology
Published: November 29, 2025
GRHL and PGR control WNT4 expression via 3D looping of conserved and species-specific enhancers.
Journal: Cell reports
Published: March 13, 2025
Dendritic cell progenitors engineered to express extracellular-vesicle-internalizing receptors enhance cancer immunotherapy in mouse models.
Journal: Nature communications
Published: October 02, 2024
Molecular and cellular consequences of mevalonate kinase deficiency.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: February 26, 2024
STING signals to NF-κB from late endolysosomal compartments using IRF3 as an adaptor.
Journal: Nature immunology
Published: November 07, 2023
Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development.
Journal: Scientific reports
Published: September 08, 2022
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Journal: Nature
Published: September 01, 2022
Posttranslational modification of microtubules by the MATCAP detyrosinase.
Journal: Science (New York, N.Y.)
Published: April 28, 2022
MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling.
Journal: Nature communications
Published: April 02, 2021
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Journal: Nature
Published: January 19, 2021
Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice.
Journal: Journal of mammary gland biology and neoplasia
Published: June 18, 2019
Last Updated: 09/26/2026